focus -WSS

focus

author：fashion 2025-08-12 08:29:52 - browse：1591

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

WSS

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Merck drug for rare lung condition set for approval in U.S.

The Readout: Lenmeldy, GLP

Covid vaccine financial winners and losers, from Pfizer to Novavax

A new ‘biological computer' targets cancer while sparing healthy cells

Vertex Pharmaceuticals may move headquarters in Boston

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Merck drug for rare lung condition set for approval in U.S.

In Memoriam: Notable people who died in 2023

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Peter Hotez and the public health issue of online harassment

Delta passengers in Vegas fall sick while waiting on flight in triple

The high cost of giving birth even with insurance

Mystery swirls around US soldier who entered North Korea days ago, officials say

Guidelines to prevent youth baseball injuries need more muscle

Steward Health Care has deal to sell doctor network to UnitedHealth

entertainment

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Judge denies Trump's request for new trial in E. Jean Carroll case

Scientists grapple with ethics of stem cell research

Stanford president’s abrupt resignation sparks debate

'CMA Fest' 2023: How to watch, who is performing and more

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

hotspot

leisure time

focus

Wikipedia